# Hyperbaric Oxygen Therapy on Insulin Resistance in Postmenopause

> **NCT06806345** · PHASE1,PHASE2 · RECRUITING · sponsor: **Cairo University** · enrollment: 40 (estimated)

## Conditions studied

- Insulin Resistance Syndrome

## Interventions

- **DEVICE:** Hyperbaric oxygen therapy
- **DRUG:** Hypoglycemic Drug

## Key facts

- **NCT ID:** NCT06806345
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-28
- **Primary completion:** 2025-03-28
- **Final completion:** 2025-04-28
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06806345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06806345, "Hyperbaric Oxygen Therapy on Insulin Resistance in Postmenopause". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06806345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*